Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

Clinical trial NCT03658330 · COMPLETED

Trial details

NCT number: NCT03658330
Sponsor: VA Connecticut Healthcare System
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder Alcohol Use Disorder

Start date: 2016-05-01
Primary completion: 2016-10-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.